
OPCH Stock Forecast & Price Target
OPCH Analyst Ratings
Bulls say
Option Care Health Inc. has demonstrated a solid financial performance with its gross profit reaching $269.0 million, representing an 8% year-over-year increase and surpassing previous estimates. In addition, the company has revised its revenue projections for 2025 upwards to a range of $5.5 billion to $5.65 billion, reflecting a 12% growth year-over-year at the midpoint. These strong financial metrics indicate a robust operational strategy and a positive outlook for the company's future growth trajectory.
Bears say
Option Care Health Inc faces significant revenue risk due to its reliance on a single customer, which represents 14% of its 2023 revenue; the potential loss of this customer could substantially impact both revenue and profitability. Additionally, the company's gross margin expansion appears constrained as the growth of lower-margin chronic therapies outpaces that of higher-margin acute therapies, posing challenges for future EBITDA margin improvement. Furthermore, any merger and acquisition activities beyond its core operations may introduce execution risks and negatively affect market sentiment, hampering near-term growth and margin stability.
This aggregate rating is based on analysts' research of Option Care Health and is not a guaranteed prediction by Public.com or investment advice.
OPCH Analyst Forecast & Price Prediction
Start investing in OPCH
Order type
Buy in
Order amount
Est. shares
0 shares